Tufts Hangs Tough on Opportunity Cost Analysis
Last week I questioned the $800 million quoted in the press and other blogs as the cost of Pfizer's torcetrapib failure (see torcetrapib: "$800 Million" Failure but Kindler Safe). I doubted...
Is Pfizer Arrogant and Superior?
The members of the online Pharma Marketing Discussion Board, which I moderate, had a lively exchange on the subject of Pfizer, torcetrapib, and drug costs over the past several days. I'd...
Betting the Pharm
Pfizer's failure to launch torcetrapib will have repercussions throughout the industry on many different levels. As a seminal event, it will rival the withdrawal of Vioxx from the market.First, it is...
torcetrapib: “$800 Million” Failure but Kindler Safe
Expect to see Pfizer’s failed attempt to bring torcetrapib to market as an oft-cited object lesson of why the costs of drugs needs to remain high. The following comment from Rich...
Pfizer’s torcetrapib: Who Knew What, When?
Reported today in the Wall Street Journal:"Pfizer Inc. halted development of a drug to boost good cholesterol that was the most important medicine in its pipeline, after more patients than expected...
Compliance, Math, and Marketers
I spent the day yesterday at eyeforpharma's 3rd Annual Patient Compliance and Adherence Congress in Philadelphia. I went mainly because I was "commissioned" by the conference organizers to be a roundtable...
Out with the Bad, In with the Good
Two of the biggest, if not THE biggest, US-based pharmaceutical companies -- Pfizer and Merck --have made separate announcements in preparation for Wall Street analyst pow wows this week.Pfizer announced a...
Off-Label Confusion
Results of the WSJ Online/Harris Interactive Health-care Poll regarding off-label use of drugs were recently published ("Adults Are Divided On Off-Label Use Of Prescription Drugs").Looking at the numbers, I would say...
Am I Dreaming, or Is This a Rozerem Ad?
Rich Meyer, author the World of DTC Marketing blog, drew my attention to a recent Wall Street Journal article entitled "Am I Dreaming, or Is This a Sleeping-Pill Spot?"Maybe the article...
Levitra Levity
A $190,000 Levitra "ad" campaign in Hong Kong--developed by Interpublic Group public-relations agency Golin Harris--increased sales of Levitra in Hong Kong by 244% from August through October, according to an article...
